 Home: PCU 4|2004: Laurence Klotz, MD: Select publications
Select publications
Aprikian AG et al. An oncology perspective on the benefits and cost of combined androgen blockade in advanced prostate cancer. Can J Urol 2003;10(5):1986-94. Abstract
Fisher LD et al. Active-control trials: How would a new agent compare with placebo? A method illustrated with clopidogrel, aspirin, and placebo. Am Heart J 2001;141(1):26-32. Abstract
Sarosdy MF et al. Comparison of goserelin and leuprolide in combined androgen blockade therapy. Urology 1998;52(1):82-8. Abstract
|
